Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Currently, the following drugs are approved for long-term treatment of obesity worldwide: Orlistat (Xenical, Xenical, Roche, Basel, Switzerland), 1999
Book your appointment today
Signs of kidney problems : markedly decreased urine output, swelling in legs or feet, persistent vomiting or diarrhea, or severe flank/back pain (possible kidney stones)
None of the information contained in the descriptions is approved by the Chief Sanitary inspectorate of Poland (GIS), the Chief Pharmaceutical Inspectorate of Poland (GIF) or the European Food Safety Authority (EFSA)
Popular GLP-1 Medications The GLP-1 landscape includes several widely prescribed options: Semaglutide (Ozempic, Wegovy): For type 2 diabetes and weight management Tirzepatide (Mounjaro): A dual GIP/GLP-1 receptor agonist with significant weight loss effects Liraglutide (Saxenda): Approved specifically for weight management Dulaglutide (Trulicity): Primarily used for type 2 diabetes management Each medication has a unique dosing schedule and side effect profile that your healthcare provider can discuss during personalized consultations
